Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufact...

FDA Recall #D-0354-2025 — Class II — March 21, 2025

Recall #D-0354-2025 Date: March 21, 2025 Classification: Class II Status: Ongoing

Product Description

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)

Reason for Recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Recalling Firm

Somerset Therapeutics Private Limited — Bengaluru, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

506,080 vials

Distribution

U.S. Nationwide

Code Information

NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026; A240342, A240347, A240385, A240391, exp. date 06/2026; NDC 70069-101-05; A240326, exp. date 05/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated